Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations

Neurology

Volumn 53, Issue 7, 1999, Pages 1584-1587

  Schneider, O ^a   Michel, U ^a   Zysk, G ^b   Dubuis, O ^c   Nau, R ^a,d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

CSF; Lipoteichoic acid; Meningitis; Streptococcus pneumoniae; Teichoic acid

Indexed keywords

LIPOTEICHOIC ACID; TEICHOIC ACID;

ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LUMBAR PUNCTURE; MALE; MORTALITY; PRIORITY JOURNAL; RATING SCALE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0032719350     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.7.1584     Document Type: Article

References (10)

1. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV, the Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990;162:1316-1323.
2. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. N Engl J Med 1993;328:21-28.
3. Kim YS, Kennedy S, Täuber MG. Toxicity of Streptococcus pneumoniae in neurons, astrocytes and microglia in vitro. J Infect Dis 1995;171:1363-1368.
4. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A. The induction of meningeal inflammation by bacterial compounds of the pneumococcal cell wall. J Infect Dis 1985;151:859-868.
5. Stuertz K, Schmidt H, Eiffert H, Schwartz P, Mäder M, Nau R. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to β-lactam antibiotics, rifamycins, trovafloxacin and quinupristindalfopristin. Antimicrob Agents Chemother 1998;42:277-281.
6. Mertsola J, Kennedy WA, Waagner D, et al. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type b meningitis. Am J Dis Child 1991;145:1099-1103.
7. Zysk G, Brück W, Gerber J, Brück Y, Prange HW, Nau R. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996;55:722-728.
8. Saéz-Llorens X, Jafari HS, Severien C, et al. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest 1991;88:2003-2011.
9. Paris MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, McCracken GH Jr. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994;38:1320-1324.
10. Nau R, Wellmer A, Soto A, et al. Rifampin reduces early mortality in experimental S. pneumoniae meningitis. J Infect Dis 1999;179:1557-1560.